Nausea, reflux, and low blood sugar risk can also increase, especially early in therapy or after dose changes
Understanding this GLP-1 microbiome connection is the difference between viewing your symptoms as temporary discomfort that resolves on its own and recognizing persistent digestive dysfunction that requires targeted support
Exenatide and lixisenatide are derived from exogenous Gila monster venom and have an exendin-4 backbone, whereas the remaining 4 commercially available GLP1RAs are modifications of endogenous GLP1 (52)
Some experts who spoke with Hunterbrook, including Dr
These natural approaches complement the gradual dose schedule by making each transition more comfortable
The study, published on July 15 in eClinical Medicine, shows that GLP-1RAs can lead to moderate reductions in binge eating severity, loss of control eating, and emotional eating